Hartmut Döhner

53PUBLICATIONS
364CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Medical mycologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Jun 25, 2026
Rapid and Reproducible Karyotyping with Long Read Sequencing in AML Patients.

|Feb 09, 2026
Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia.

Rabea Mecklenbrauck, Angela Villaverde Ramiro, Eric Sträng

|Jan 14, 2026
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY study.

Alberto Hernández-Sánchez, Ángela Villaverde Ramiro, Eric Sträng

|Jan 06, 2026
A phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

Hartmut Döhner, Daniela Späth, Maral Saadati

|Nov 19, 2025
Patient involvement in the design of ALIDHE: a study of ivosidenib + azacitidine in newly diagnosed <i>IDH1</i> mutant AML.

Samantha Nier, Jana Pelouchova, Ralph Hills

|Nov 16, 2025
ALIDHE phase 3b study design: ivosidenib + azacitidine in adults with newly diagnosed <i>IDH1</i> mutant acute myeloid leukemia.

Paresh Vyas, Sam Salek, Susana Vives

Pageof 9

Frequent Collaborators

12 joint publications

Konstanze Döhner

11 joint publications

Michael Heuser

10 joint publications

Courtney D DiNardo

7 joint publications

Andrew H Wei